Wassiti, Monash Institute of Pharmaceutical SciencesA novel vaccine that boosts immunity against tuberculosis (TB) has been shown to be ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

FOX 2 - A 100-year-old vaccine is getting a fresh look as it's being studied to treat an autoimmune disease. One local child who's hoping to help change the world for people with type 1 diabetes.

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...

David Ussery and Brian Delavan discuss bioinformatics into TB surveillance, presenting a new approach to tackling this ...

Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel ...

Tuberculosis may seem like a historic malady, but it’s still the world’s deadliest infectious disease. Here’s what you need ...

One of the key launch points for the modern biotechnology industry was not in the Bay Area or San Diego or Cambridge, ...

Dr. Krishna Maharjan studies chromosomes and cell structures. One of Nepal’s leading cytogeneticists, he broadened my ...

Introduction Globally, tuberculosis (TB) remains one of the leading infectious causes of death, with 1.3 million deaths.

In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population ...